Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Prozac

Executive Summary

Email reminder service for fluoxetine patients who signed up at www.prozac.com ends due to low level of interest, Lilly says. A June 27 email announcing the end of the service inadvertently revealed email addresses of 600 program participants. Pediatric exclusivity for Prozac expires Aug. 2

You may also be interested in...



Lilly Evaluating Audit Committee Responsibilities In Light Of New NYSE Rules

Lilly is evaluating the legal and regulatory oversight responsibilities of its audit committee in light of New York Stock Exchange Corporate Governance Rules

Lilly Evaluating Audit Committee Responsibilities In Light Of New NYSE Rules

Lilly is evaluating the legal and regulatory oversight responsibilities of its audit committee in light of New York Stock Exchange Corporate Governance Rules

Texas Medical Privacy Law: Rx Industry Seeks Amendment Before Sept. 1

The pharmaceutical industry is attempting to amend a Texas medical privacy law that would restrict drug companies' use of patient information before the law's Sept. 1 compliance deadline

Related Content

UsernamePublicRestriction

Register

PS038147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel